Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
145.59
+8.74 (6.39%)
Aug 14, 2025, 3:12 PM CST
575.28%
Market Cap 23.19B
Revenue (ttm) 419.02M
Net Income (ttm) -170.15M
Shares Out 159.27M
EPS (ttm) -1.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,190,408
Average Volume 17,353,694
Open 116.00
Previous Close 136.85
Day's Range 116.00 - 150.20
52-Week Range 17.20 - 146.25
Beta 1.23
RSI 79.02
Earnings Date Aug 28, 2025

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, anti-infection, liver diseases, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.

Financial Statements

News

There is no news available yet.